206 related articles for article (PubMed ID: 36295550)
1. The Association between Admission Procalcitonin Level and The Severity of COVID-19 Pneumonia: A Retrospective Cohort Study.
Aon M; Alsaeedi A; Alzafiri A; Ibrahim MM; Al-Shammari A; Al-Shammari O; Tawakul M; Taha S; Alherz N; Alshammari J; Albazee E; Alharbi T; Alshammari D; Alenezi Z; Alenezi M; Aldouseri S; Eyadah M; Aldhafeeri M; Aoun AH
Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295550
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
[TBL] [Abstract][Full Text] [Related]
3. High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department.
Tong-Minh K; van der Does Y; Engelen S; de Jong E; Ramakers C; Gommers D; van Gorp E; Endeman H
BMC Infect Dis; 2022 Feb; 22(1):165. PubMed ID: 35189826
[TBL] [Abstract][Full Text] [Related]
4. Glycosylated hemoglobin as a predictor of mortality in severe pneumonia by COVID-19.
Sánchez Díaz JS; Peniche Moguel KG; González Escudero EA; Del Carpio Orantes L; Monares Zepeda E; Perez Nieto OR; Zamarron Lopez EI; Deloya Tomas E; Estrada Gonzalez FE; Díaz Torres J; Escarraman Martinez D; Guerrero Gutierrez MA
Expert Rev Respir Med; 2021 Aug; 15(8):1077-1082. PubMed ID: 33955309
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with poor outcomes among hospitalized patients with COVID-19: Experience from a MERS-CoV referral hospital.
Barry M; Alotaibi M; Almohaya A; Aldrees A; AlHijji A; Althabit N; Alhasani S; Akkielah L; AlRajhi A; Nouh T; Temsah MH; Al-Tawfiq JA
J Infect Public Health; 2021 Nov; 14(11):1658-1665. PubMed ID: 34627061
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with critical care requirements in diabetic patients treated with dexamethasone for COVID-19 infection in the first wave of the pandemia.
Batule S; Soldevila B; Figueredo C; Julián MT; Egea-Cortés L; Reyes-Ureña J; Casabona J; Mateu L; Paredes R; Clotet B; López R; Puig-Domingo M; Alonso N
Front Endocrinol (Lausanne); 2022; 13():1009028. PubMed ID: 36619546
[TBL] [Abstract][Full Text] [Related]
8. Elevated procalcitonin concentrations in severe Covid-19 may not reflect bacterial co-infection.
Heer RS; Mandal AK; Kho J; Szawarski P; Csabi P; Grenshaw D; Walker IA; Missouris CG
Ann Clin Biochem; 2021 Sep; 58(5):520-527. PubMed ID: 34018843
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia.
Roy A; Powers HR; Craver EC; Nazareno MD; Yarrarapu SNS; Sanghavi DK
J Clin Pharm Ther; 2022 Feb; 47(2):243-247. PubMed ID: 34766357
[TBL] [Abstract][Full Text] [Related]
10. "Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study".
Entrenas Castillo M; Entrenas Costa LM; Vaquero Barrios JM; Alcalá Díaz JF; López Miranda J; Bouillon R; Quesada Gomez JM
J Steroid Biochem Mol Biol; 2020 Oct; 203():105751. PubMed ID: 32871238
[TBL] [Abstract][Full Text] [Related]
11. Digestive system involvement and clinical outcomes among COVID-19 patients: A retrospective cohort study from Qatar.
Khan MU; Mushtaq K; Alsoub DH; Iqbal P; Ata F; Chaudhry HS; Iqbal F; Balaraju G; Maslamani MAA; Varughese B; Singh R; Ejji KA; Kaabi SA; Kamel YM; Butt AA
World J Gastroenterol; 2021 Dec; 27(46):7995-8009. PubMed ID: 35046626
[TBL] [Abstract][Full Text] [Related]
12. Procalcitonin Levels in COVID-19 Patients Are Strongly Associated with Mortality and ICU Acceptance in an Underserved, Inner City Population.
Feng T; James A; Doumlele K; White S; Twardzik W; Zahid K; Sattar Z; Ukponmwan O; Nakeshbandi M; Chow L; Foronjy R
Medicina (Kaunas); 2021 Oct; 57(10):. PubMed ID: 34684107
[No Abstract] [Full Text] [Related]
13. Association of body mass index with severity and mortality of COVID-19 pneumonia: a two-center, retrospective cohort study from Wuhan, China.
Wu X; Li C; Chen S; Zhang X; Wang F; Shi T; Li Q; Lin L
Aging (Albany NY); 2021 Mar; 13(6):7767-7780. PubMed ID: 33761466
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria.
Barrasa H; Rello J; Tejada S; Martín A; Balziskueta G; Vinuesa C; Fernández-Miret B; Villagra A; Vallejo A; San Sebastián A; Cabañes S; Iribarren S; Fonseca F; Maynar J;
Anaesth Crit Care Pain Med; 2020 Oct; 39(5):553-561. PubMed ID: 32278670
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and outcome of Covid-19 illness and predictors of in-hospital mortality in Saudi Arabia.
Abolfotouh MA; Musattat A; Alanazi M; Alghnam S; Bosaeed M
BMC Infect Dis; 2022 Dec; 22(1):950. PubMed ID: 36526994
[TBL] [Abstract][Full Text] [Related]
16. Health outcomes and economic burden of hospitalized COVID-19 patients in the United States.
Di Fusco M; Shea KM; Lin J; Nguyen JL; Angulo FJ; Benigno M; Malhotra D; Emir B; Sung AH; Hammond JL; Stoychev S; Charos A
J Med Econ; 2021; 24(1):308-317. PubMed ID: 33555956
[TBL] [Abstract][Full Text] [Related]
17. Cytokine storm in severe COVID-19 pneumonia.
Gürsoy B; Sürmeli CD; Alkan M; Satıcı C; Altunok ES; Kamat S; Demirok B; Demirkol MA; Börü A
J Med Virol; 2021 Sep; 93(9):5474-5480. PubMed ID: 33963559
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of procalcitonin in hospitalized COVID-19 patients and clinical outcomes of antibiotic use stratified by procalcitonin levels.
So W; Simon MS; Choi JJ; Wang TZ; Williams SC; Chua J; Kubin CJ
Intern Emerg Med; 2022 Aug; 17(5):1405-1412. PubMed ID: 35277828
[TBL] [Abstract][Full Text] [Related]
19. Severe SARS-Cov2 pneumonia in vaccinated patients: a multicenter cohort study.
Mirouse A; Friol A; Moreau AS; Jung B; Jullien E; Bureau C; Djibré M; de Prost N; Zafrani L; Argaud L; Reuter D; Calvet L; de Montmollin E; Benghanem S; Pichereau C; Pham T; Cacoub P; Biard L; Saadoun D
Sci Rep; 2023 Feb; 13(1):1902. PubMed ID: 36732353
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of corticosteroids in non-intensive care unit patients with COVID-19 pneumonia from the New York Metropolitan region.
Majmundar M; Kansara T; Lenik JM; Park H; Ghosh K; Doshi R; Shah P; Kumar A; Amin H; Chaudhari S; Habtes I
PLoS One; 2020; 15(9):e0238827. PubMed ID: 32903258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
